How to Interpret a Genome-wide Association Study Topic Collections

Genome-wide association (GWA) studies use high-throughput genotyping technologies to assay hundreds of thousands of single-nucleotide polymorphisms (SNPs) and relate them to clinical conditions and measurable traits. Since 2005, nearly 100 loci for as many as 40 common diseases and traits have been identified and replicated in GWA studies, many in genes not previously suspected of having a role in the disease under study, and some in genomic regions containing no known genes. GWA studies are an important advance in discovering genetic variants influencing disease but also have important limitations, including their potential for false-positive and false-negative results and for biases related to selection of study participants and genotyping errors. Although these studies are clearly many steps removed from actual clinical use, and specific applications of GWA findings in prevention and treatment are actively being pursued, at present these studies mainly represent a valuable discovery tool for examining genomic function and clarifying pathophysiologic mechanisms. This article describes the design, interpretation, application, and limitations of GWA studies for clinicians and scientists for whom this evolving science may have great relevance.

[1]  E. Faerstein,et al.  A DICTIONARY OF EPIDEMIOLOGY , 2016 .

[2]  Miquel Porta,et al.  A Dictionary of Epidemiology , 2008 .

[3]  N. Cook,et al.  Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. , 2008, Clinical chemistry.

[4]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[5]  L. Shulman,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2008 .

[6]  G. Abecasis,et al.  Optimal designs for two‐stage genome‐wide association studies , 2007, Genetic epidemiology.

[7]  Zhaohui S. Qin,et al.  A second generation human haplotype map of over 3.1 million SNPs , 2007, Nature.

[8]  L. Liang,et al.  A genome-wide association study of global gene expression , 2007, Nature Genetics.

[9]  M. McCarthy,et al.  Genetic studies of diabetes following the advent of the genome-wide association study: where do we go from here? , 2007, Diabetologia.

[10]  Anbupalam Thalamuthu,et al.  TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. , 2007, The New England journal of medicine.

[11]  Kari Stefansson,et al.  Common Sequence Variants in the LOXL1 Gene Confer Susceptibility to Exfoliation Glaucoma , 2007, Science.

[12]  Richa Saxena,et al.  A common variant of HMGA2 is associated with adult and childhood height in the general population , 2007, Nature Genetics.

[13]  Sudha Seshadri,et al.  The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports , 2007, BMC Medical Genetics.

[14]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[15]  Joseph T. Glessner,et al.  A genome-wide association study identifies KIAA0350 as a type 1 diabetes gene , 2007, Nature.

[16]  Peter Kraft,et al.  Drinking from the fire hose--statistical issues in genomewide association studies. , 2007, The New England journal of medicine.

[17]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[18]  Steven Gallinger,et al.  Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24 , 2007, Nature Genetics.

[19]  Oliver Sieber,et al.  A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 , 2007, Nature Genetics.

[20]  Gonçalo R. Abecasis,et al.  Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma , 2007, Nature.

[21]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[22]  R. A. Bailey,et al.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes , 2007, Nature Genetics.

[23]  D. Gudbjartsson,et al.  Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer , 2007, Nature Genetics.

[24]  Lester L. Peters,et al.  Genome-wide association study identifies novel breast cancer susceptibility loci , 2007, Nature.

[25]  S. Mccarroll,et al.  Copy-number variation and association studies of human disease , 2007, Nature Genetics.

[26]  P. Donnelly,et al.  Replicating genotype–phenotype associations , 2007, Nature.

[27]  Winnie S. Liang,et al.  GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.

[28]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[29]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[30]  G. Abecasis,et al.  A Genome-Wide Association Study of Type 2 Diabetes in Finns Detects Multiple Susceptibility Variants , 2007, Science.

[31]  W. Willett,et al.  A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer , 2007, Nature Genetics.

[32]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[33]  P. Fearnhead,et al.  Genome-wide association study of prostate cancer identifies a second risk locus at 8q24 , 2007, Nature Genetics.

[34]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[35]  Rebecca F. Halperin,et al.  A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.

[36]  Harlan M Krumholz,et al.  Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. , 2007, JAMA.

[37]  John P A Ioannidis,et al.  On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies. , 2007, International journal of epidemiology.

[38]  J. Pritchard,et al.  Overcoming the winner's curse: estimating penetrance parameters from case-control data. , 2007, American journal of human genetics.

[39]  K. Christensen,et al.  What genome-wide association studies can do for medicine. , 2007, The New England journal of medicine.

[40]  Simon Heath,et al.  Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4 , 2007, PLoS genetics.

[41]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[42]  J. Gulcher,et al.  Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution , 2007, Nature Genetics.

[43]  R. Hoover.  The evolution of epidemiologic research: from cottage industry to "big" science. , 2007, Epidemiology.

[44]  Chi Pui Pang,et al.  HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.

[45]  Thomas Lengauer,et al.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.

[46]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[47]  Francis S. Collins,et al.  Genes, environment and the value of prospective cohort studies , 2006, Nature Reviews Genetics.

[48]  Andrzej S Krolewski,et al.  Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes. , 2006, Journal of the American Society of Nephrology : JASN.

[49]  J. Todd.  Statistical false positive or true disease pathway? , 2006, Nature Genetics.

[50]  Christian Gieger,et al.  A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization , 2006, Nature Genetics.

[51]  Peter Holmans,et al.  Effects of Differential Genotyping Error Rate on the Type I Error Probability of Case-Control Studies , 2006, Human Heredity.

[52]  Don H. Anderson,et al.  Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts , 2006, Annals of medicine.

[53]  Qiong Yang,et al.  Power and type I error rate of false discovery rate approaches in genome-wide association studies , 2005, BMC Genetics.

[54]  L. Cardon,et al.  Replication Publication , 2005, PLoS biology.

[55]  M. Daly,et al.  Genome-wide association studies for common diseases and complex traits , 2005, Nature Reviews Genetics.

[56]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[57]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[58]  Nathaniel Rothman,et al.  Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology Studies , 2004 .

[59]  Nathaniel Rothman,et al.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. , 2004, Journal of the National Cancer Institute.

[60]  J. Denis,et al.  Partnership experiences: Involving decision-makers in the research process , 2003, Journal of health services research & policy.

[61]  Chiara Sabatti,et al.  False discovery rate in linkage and association genome screens for complex disorders. , 2003, Genetics.

[62]  Aravinda Chakravarti,et al.  Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test. , 2003, American journal of human genetics.

[63]  L. Cardon,et al.  Population stratification and spurious allelic association , 2003, The Lancet.

[64]  Nathaniel Rothman,et al.  Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[65]  John S Witte,et al.  Point: population stratification: a problem for case-control studies of candidate-gene associations? , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[66]  S. Gabriel,et al.  The Structure of Haplotype Blocks in the Human Genome , 2002, Science.

[67]  R. Myers,et al.  Candidate-gene approaches for studying complex genetic traits: practical considerations , 2002, Nature Reviews Genetics.

[68]  J. Hirschhorn,et al.  A comprehensive review of genetic association studies , 2002, Genetics in Medicine.

[69]  L. Palmer,et al.  Genomewide scans of complex human diseases: true linkage is hard to find. , 2001, American journal of human genetics.

[70]  J Lomas,et al.  Using 'linkage and exchange' to move research into policy at a Canadian foundation. , 2000, Health affairs.

[71]  K. Roeder,et al.  Genomic Control for Association Studies , 1999, Biometrics.

[72]  Francis S. Collins,et al.  Variations on a Theme: Cataloging Human DNA Sequence Variation , 1997, Science.

[73]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[74]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[75]  J. MacDonald,et al.  Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative. , 1988, Drugs.